|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/14 Bio Key International Inc 10-K 12/31/13 99:9.7M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.14M
2: EX-10 Exhibit 10.35 HTML 95K
3: EX-10 Exhibit 10.36 HTML 95K
4: EX-10 Exhibit 10.37 HTML 93K
5: EX-10 Exhibit 10.38 HTML 94K
6: EX-10 Exhibit 10.39 HTML 93K
7: EX-10 Exhibit 10.40 HTML 45K
8: EX-10 Exhibit 10.41 HTML 43K
9: EX-10 Exhibit 10.42 HTML 100K
10: EX-10 Exhibit 10.43 HTML 40K
11: EX-10 Exhibit 10.44 HTML 57K
12: EX-23 Exhibit 23.1 HTML 28K
13: EX-31 Exhibit 31.1 HTML 38K
14: EX-31 Exhibit 31.2 HTML 38K
15: EX-32 Exhibit 32.1 HTML 32K
16: EX-32 Exhibit 32.2 HTML 31K
71: R1 Document And Entity Information HTML 56K
58: R2 Consolidated Balance Sheets HTML 102K
69: R3 Consolidated Balance Sheets (Parentheticals) HTML 37K
73: R4 Consolidated Statements of Operations HTML 83K
92: R5 Consolidated Statements of Stockholders' Equity HTML 68K
(Deficit)
60: R6 Consolidated Statements of Cash Flows HTML 119K
68: R7 Note A - The Company and Summary of Significant HTML 140K
Accounting Policies
52: R8 Note B - Factoring HTML 47K
42: R9 Note C - Fair Values of Financial Instruments HTML 74K
93: R10 Note D - Concentration of Risk HTML 55K
75: R11 Note E - Equipment and Leashold Improvements HTML 55K
74: R12 Note F - Intangible Assets HTML 60K
80: R13 Note G - Accrued Laibilites HTML 54K
81: R14 Note H - Related Party HTML 34K
78: R15 Note I - Deferred Revenue HTML 43K
82: R16 Note J - Notes Payable HTML 37K
70: R17 Note K - Segment Information HTML 36K
72: R18 Note L - Commitments HTML 44K
77: R19 Note M - Equity HTML 147K
99: R20 Note N - Stock Options HTML 184K
88: R21 Note O - Income Taxes HTML 81K
64: R22 Note P - Profit Sharing Plan HTML 30K
76: R23 Note Q - Earnings Per Share (Eps) HTML 58K
66: R24 Note R - Subsequent Events HTML 30K
34: R25 Accounting Policies, by Policy (Policies) HTML 197K
89: R26 Note A - The Company and Summary of Significant HTML 111K
Accounting Policies (Tables)
96: R27 Note B - Factoring (Tables) HTML 61K
47: R28 Note C - Fair Values of Financial Instruments HTML 70K
(Tables)
46: R29 Note D - Concentration of Risk (Tables) HTML 53K
50: R30 Note E - Equipment and Leashold Improvements HTML 53K
(Tables)
51: R31 Note F - Intangible Assets (Tables) HTML 58K
54: R32 Note G - Accrued Laibilites (Tables) HTML 52K
30: R33 Note I - Deferred Revenue (Tables) HTML 42K
86: R34 Note L - Commitments (Tables) HTML 40K
62: R35 Note M - Equity (Tables) HTML 100K
65: R36 Note N - Stock Options (Tables) HTML 177K
37: R37 Note O - Income Taxes (Tables) HTML 77K
98: R38 Note Q - Earnings Per Share (Eps) (Tables) HTML 55K
23: R39 Note A - The Company and Summary of Significant HTML 50K
Accounting Policies (Details)
55: R40 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Summary of
Accounts Receivables
91: R41 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Allowance for
Doubtful Accounts
36: R42 Note A - The Company and Summary of Significant HTML 36K
Accounting Policies (Details) - Estimated Useful
Lives for Depreciation and Amortization
45: R43 Note A - The Company and Summary of Significant HTML 33K
Accounting Policies (Details) - Share-Based
Compensation Expenses for Continuing Operations
49: R44 Note A - The Company and Summary of Significant HTML 39K
Accounting Policies (Details) - Valuation
Assumptions for Stock Options
59: R45 Note B - Factoring (Details) HTML 33K
29: R46 Note B - Factoring (Details) - Due from Factor HTML 33K
41: R47 Note C - Fair Values of Financial Instruments HTML 38K
(Details) - Fair Value Measurement of Warrant
Liabilities and Derivative Liabilities
25: R48 Note C - Fair Values of Financial Instruments HTML 41K
(Details) - Fair Value Measurements Using
Significant Unobservable Inputs
90: R49 Note D - Concentration of Risk (Details) HTML 29K
35: R50 Note D - Concentration of Risk (Details) - Revenue HTML 32K
Concentration Risk by Major Customer
87: R51 Note D - Concentration of Risk (Details) - HTML 32K
Accounts Receivable Concentration Risk by Major
Customer
38: R52 Note E - Equipment and Leashold Improvements HTML 30K
(Details)
56: R53 Note E - Equipment and Leashold Improvements HTML 40K
(Details) - Summary of Equipment and Leasehold
Improvements
24: R54 Note F - Intangible Assets (Details) HTML 45K
28: R55 Note F - Intangible Assets (Details) - Summary of HTML 36K
Intangible Assets
48: R56 Note G - Accrued Laibilites (Details) - Summary of HTML 55K
Accrued Liabilities
32: R57 Note H - Related Party (Details) HTML 35K
94: R58 Note I - Deferred Revenue (Details) - Components HTML 32K
of Deferred Revenue
61: R59 Note J - Notes Payable (Details) HTML 53K
79: R60 Note K - Segment Information (Details) HTML 33K
40: R61 Note L - Commitments (Details) HTML 29K
43: R62 Note L - Commitments (Details) - Future Minimum HTML 44K
Rental Commitments of Non-Cancelable Operating
Leases
85: R63 Note M - Equity (Details) HTML 146K
83: R64 Note M - Equity (Details) - Summary of Warrant HTML 49K
Activity
63: R65 Note N - Stock Options (Details) HTML 67K
84: R66 Note N - Stock Options (Details) - Option Activity HTML 89K
39: R67 Note N - Stock Options (Details) - Options HTML 56K
Outstanding and Exercisable
67: R68 Note O - Income Taxes (Details) HTML 30K
95: R69 Note O - Income Taxes (Details) - Components of HTML 49K
Deferred Taxes
27: R70 Note O - Income Taxes (Details) - Reconciliation HTML 34K
of the Effective Income Tax Rate to US Federal
Statutory Income Tax Rate
33: R71 Note P - Profit Sharing Plan (Details) HTML 29K
57: R72 Note Q - Earnings Per Share (EPS) (Details) - HTML 37K
Securities Excluded from the Diluted Per Share
Calculation
31: R73 Note R - Subsequent Events (Details) HTML 30K
97: XML IDEA XML File -- Filing Summary XML 133K
26: EXCEL IDEA Workbook of Financial Reports XLSX 179K
44: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.54M
17: EX-101.INS XBRL Instance -- bkyi-20131231 XML 1.69M
19: EX-101.CAL XBRL Calculations -- bkyi-20131231_cal XML 111K
20: EX-101.DEF XBRL Definitions -- bkyi-20131231_def XML 807K
21: EX-101.LAB XBRL Labels -- bkyi-20131231_lab XML 1.18M
22: EX-101.PRE XBRL Presentations -- bkyi-20131231_pre XML 766K
18: EX-101.SCH XBRL Schema -- bkyi-20131231 XSD 199K
53: ZIP XBRL Zipped Folder -- 0001437749-14-005560-xbrl Zip 180K
| ex9.htm |
Exhibit 10.43
THIRD AMENDMENT TO LEASE AGREEMENT
This Third Amendment to Lease Agreement (this “Third Amendment”) made as of this __ day of June, 2013 by and between Victor AOP, Inc., as Landlord, and BIO-key International, Inc., as Tenant.
WHEREAS:
A. Landlord and Tenant are parties to a certain lease dated June 2, 2004 as amended by a First Amendment to Lease dated in August, 2004 and Second Amendment and Lease dated January, 2009 (collectively, the “Lease”) respecting 4,179 gross square feet of floor space (the “Premises”) in Allaire Office Park, Building D, Route 138, Wall Township, New Jersey; and
B. The term of the Lease expires on September 30, 2014; and
C. The Landlord and Tenant wish do relocate the office to Building A, Suite 102 representing 4517 gross square feet in the Allaire Office Park.
D. The expected date of this move will be at or near October 1, 2013, with a date certain agreement signed upon occupancy.
E. Landlord and Tenant mutually desire to extend the term of the Lease for five (5) years, subject to and in accordance with the terms of this Third Amendment.
NOW, THEREFORE, for good and valuable consideration, the receipt of which is hereby acknowledged, the parties agree as follows:
|
1. |
The term of the Lease is hereby renewed commencing as of September 1, 2013 and terminating on August 30, 2018 (the “Renewal Term”). |
|
2. |
During the Renewal Term all terms and conditions of the Lease shall remain the same, except that: |
|
a. |
During the initial year of the Renewal Term (September 1, 2013) the Base Rent shall be at the rate of $103,891.00 per annum, payable in monthly installments of $8657.58 in accordance with the terms of the Lease. The rent will be subject to an annual increase of 3% commencing September 1, 2014 and each year thereafter. |
|
4. |
For purposes of this Third Amendment, capitalized terms used herein shall have the same meanings ascribed to them in the Lease, unless otherwise defined herein. |
|
6. |
The preamble to this Third Amendment is incorporated by reference into the body of this Third Amendment. |
IN WITNESS WHEREOF, the parties hereto have hereunto set their hands and seals and caused these presents to be properly signed by authorized signatories as of the day and year Second above written.
|
ATTEST OR WITNESS: |
|
VICTOR AOP, INC., Landlord | |
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
RAN KOROLIK, Vice President |
|
ATTEST OR WITNESS: |
|
BIO-KEY INTERNATIONAL, INC., Tenant | |
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
Michael DePasquale, President |
-2-
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 8/30/18 | ||||
| 9/30/14 | 10-Q | |||
| 9/1/14 | ||||
| Filed on: | 3/31/14 | 10-Q, 8-K | ||
| For Period end: | 12/31/13 | CORRESP, EFFECT, S-1/A, UPLOAD | ||
| 10/1/13 | ||||
| 9/1/13 | ||||
| 6/2/04 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/30/24 Bio Key International Inc. S-1 5:346K RDG Filings/FA 10/26/23 Bio Key International Inc. S-1/A 9:1M RDG Filings/FA 10/16/23 Bio Key International Inc. S-1 4:473K RDG Filings/FA 6/15/23 Bio Key International Inc. S-1 136:12M RDG Filings/FA 4/01/22 Bio Key International Inc. 10-K 12/31/21 107:9.4M RDG Filings/FA 4/16/21 Bio Key International Inc. POS AM 3:2M RDG Filings/FA 3/29/21 Bio Key International Inc. 10-K 12/31/20 109:8.7M RDG Filings/FA |